Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex322_9.htm |
| 10-K - 10-K - TETRAPHASE PHARMACEUTICALS INC | ttph-10k_20191231.htm |
| EX-32.1 - EX-32.1 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex321_10.htm |
| EX-31.2 - EX-31.2 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex312_12.htm |
| EX-31.1 - EX-31.1 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex311_6.htm |
| EX-23.1 - EX-23.1 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex231_734.htm |
| EX-10.20 - EX-10.20 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex1020_706.htm |
| EX-4.10 - EX-4.10 - TETRAPHASE PHARMACEUTICALS INC | ttph-ex410_680.htm |
Exhibit 21.1
SUBSIDIARIES OF THE REGISTRANT
|
Name |
|
Jurisdiction of Organization |
|
Percentage Ownership |
|
|
|
|
|
|
|
Tetraphase Pharma Securities, Inc. |
|
Massachusetts |
|
100% |
|
Tetraphase Ireland Limited |
|
Republic of Ireland |
|
100% |
|
Tetraphase UK Limited |
|
United Kingdom |
|
100% |